Holen Sie sich die Stockscreener-App
23.53
9.57%
-2.49
Pacira Biosciences Inc Aktie (PCRX) Neueste Nachrichten
Pacira Stock (-9.6%): EXPAREL Decel Spooks the Street - Trefis
How Investors May Respond To Pacira BioSciences (PCRX) Activist Pressure Amid Buybacks And Rising EXPAREL Revenue - Yahoo Finance
Pacira BioSciences (PCRX) Rating Reiterated as 'Buy' by HC Wainw - GuruFocus
What Analysts Are Saying About Pacira BioSciences Stock - Benzinga
Pacira BioSciences (PCRX) Receives 'Buy' Rating from Needham | P - GuruFocus
Pacira BioSciences Stock Pre-Market (-9.7%): Weak Preliminary 2025 Revenue - Trefis
Will Pacira BioSciences Inc. stock benefit from AI adoptionJuly 2025 Big Picture & Growth Focused Investment Plans - ulpravda.ru
Why Pacira BioSciences Inc. stock remains resilient2025 Big Picture & Detailed Earnings Play Strategies - ulpravda.ru
Signal Recap: Will Pacira BioSciences Inc. stock continue upward momentumJuly 2025 Catalysts & Short-Term High Return Ideas - ulpravda.ru
Pacira BioSciences (PCRX) Shares Dip After Revenue Outlook Cut - GuruFocus
Pacira (PCRX) Reports Strong 2025 Performance, Eyes Future Growt - GuruFocus
Pacira drops after adjusting 2025 revenue below consensus - MSN
Pacira reports record EXPAREL sales with 7% volume growth in Q4 By Investing.com - Investing.com South Africa
Pacira reports record EXPAREL sales with 7% volume growth in Q4 - Investing.com Nigeria
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues - The Manila Times
Is Pacira BioSciences Inc. stock dividend yield sustainableJuly 2025 Sector Moves & Free Reliable Trade Execution Plans - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Investors to Inquire about Securities Investigation - ACCESS Newswire
Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences - markets.businessinsider.com
DOMA Perpetual Capital to offer nominees for Pacira BioSciences board - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Shareholders to Connect - ACCESS Newswire
Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Aug Chart Watch: How Pacira BioSciences Inc 82P stock reacts to weak economyQuarterly Portfolio Summary & High Accuracy Investment Entry Signals - moha.gov.vn
Bull of the Day: Pacira BioSciences (PCRX) - MSN
(PCRX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Shareholders to Reach Out - ACCESS Newswire
PCRX (Pacira BioSciences) 3-Year FCF Growth Rate : 30.20% (As of Sep. 2025) - GuruFocus
Big and small, Bay Area companies catch eye of activist shareholders at year's endSan Francisco Business Times - The Business Journals
Pacira Biosciences Shareholder Seeks Board Changes, Pushes for Sale - marketscreener.com
DOMA to nominate three directors to Pacira board, urges company sale By Investing.com - Investing.com Nigeria
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
DOMA Perpetual Pushes for Strategic Changes at Pacira BioSciences (PCRX) - GuruFocus
Pacira (PCRX) Faces Push for Leadership Change and Strategic Rev - GuruFocus
DOMA to nominate three directors to Pacira board, urges company sale - Investing.com India
Doma Perpetual Capital Management asserts Pacira BioSciences's board to pursue sale of company - MarketScreener
DOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc. - Nasdaq
Pacira BioSciences, Inc. $PCRX Shares Sold by Simplify Asset Management Inc. - MarketBeat
Pacer Advisors Inc. Trims Position in Pacira BioSciences, Inc. $PCRX - MarketBeat
Pacira BioSciences, Inc. (PCRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
75,598 Shares in Pacira BioSciences, Inc. $PCRX Purchased by Exchange Traded Concepts LLC - MarketBeat
Pacira BioSciences (PCRX): How the New PROBE Consortium Partnership Shapes Its Current Valuation - Sahm
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Will Neelam Linens and Garments (India) Limited Benefit From Sector TailwindsConsumer Goods Stocks & Free Stock Index Interpretations - bollywoodhelpline.com
OA Gets a Data-Driven PROBE Makeover - Orthopedics This Week
Pacira BioSciences, Inc. (PCRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
How Investors May Respond To Pacira BioSciences (PCRX) Joining AI-Driven PROBE Osteoarthritis Consortium - Sahm
Pacira BioSciences (PCRX) price target decreased by 18.47% to 30.77 - MSN
Price-Driven Insight from (PCRX) for Rule-Based Strategy - Stock Traders Daily
Assenagon Asset Management S.A. Sells 250,594 Shares of Pacira BioSciences, Inc. $PCRX - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Investors to Connect - ACCESS Newswire
Will Pacira BioSciences Inc. stock maintain momentum in 2025Stop Loss & Weekly Breakout Opportunity Watchlist - Улправда
Is Pacira BioSciences Stock Built to Withstand a Pullback? - Trefis
Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care - Ortho Spine News
Will Pacira BioSciences Inc. (82P) stock deliver stable dividendsJuly 2025 Rallies & Risk Controlled Stock Alerts - Улправда
How geopolitical tensions affect Pacira BioSciences Inc. stockWeekly Profit Report & Safe Capital Preservation Plans - DonanımHaber
Why Pacira BioSciences Inc. stock remains a top recommendationJuly 2025 PreEarnings & Short-Term High Return Strategies - DonanımHaber
How rising interest rates impact Pacira BioSciences Inc. stockQuarterly Market Summary & Daily Stock Momentum Reports - DonanımHaber
Pacira BioSciences (PCRX): Assessing Valuation After New PROBE Consortium Osteoarthritis AI Initiative - Sahm
Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
How risky is Pacira BioSciences Inc. stock nowJuly 2025 Highlights & Free Reliable Trade Execution Plans - Улправда
Pacira (PCRX) Joins Global Effort to Enhance Osteoarthritis Rese - GuruFocus
0.37%
1.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):